6-YEAR EXPERIENCE WITH A COMPREHENSIVE APPROACH TO THE TREATMENT OF RECURRENT CHILDHOOD ACUTE LYMPHOBLASTIC-LEUKEMIA (ALL-REZ BFM 85) - A RELAPSE STUDY OF THE BFM GROUP

被引:0
|
作者
HENZE, G
FENGLER, R
HARTMANN, R
KORNHUBER, B
JANKASCHAUB, G
NIETHAMMER, D
RIEHM, H
机构
关键词
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:1166 / 1172
页数:7
相关论文
共 50 条
  • [41] ALL-BFM 95 Treatment in Turkish Children with Acute Lymphoblastic Leukemia-Experience of a Single Center
    Kocak, Ulker
    Gursel, Turkiz
    Kaya, Zuhre
    Aral, Yusuf Ziya
    Albayrak, Meryem
    Keskin, Ebru Yilmaz
    Belen, Burcu
    Isik, Melek
    Oner, Nergiz
    PEDIATRIC HEMATOLOGY AND ONCOLOGY, 2012, 29 (02) : 130 - 140
  • [42] Bone marrow transplantation (BMT) offers limited benefit in the treatment of relapsed childhood T-cell-leukemia: Results of four consecutive ALL-REZ BFM studies
    Schmid, H
    Linderkamp, C
    Hartmann, R
    Fengler, R
    Henze, G
    BLOOD, 1995, 86 (10) : 1523 - 1523
  • [43] Treatment results in childhood acute lymphoblastic leukemia with a modified ALL-BFM'90 protocol: lack of improvement in high-risk group
    Sackmann-Muriel, F
    Felice, MS
    Zubizarreta, PA
    Alfaro, E
    Gallego, M
    Rossi, J
    Cygler, AM
    LEUKEMIA RESEARCH, 1999, 23 (04) : 331 - 340
  • [44] PROSPECTIVE-STUDY OF THE IN-VITRO PREDNISOLONE RESISTANCE IN CHILDHOOD ACUTE LYMPHOBLASTIC-LEUKEMIA - A NEW RISK FACTOR IN BFM-ORIENTED TREATMENT
    PIETERS, R
    KASPERS, GJL
    VANWERING, ER
    VANDERDOESVANDENBERG, A
    VEERMAN, AJP
    BLOOD, 1993, 82 (10) : A194 - A194
  • [45] INCIDENCE, CLINICAL CHARACTERISTICS, AND PROGNOSTIC-SIGNIFICANCE OF IMMUNOLOGICAL SUBTYPES IN CHILDHOOD ACUTE LYMPHOBLASTIC-LEUKEMIA - EXPERIENCE OF THERAPY STUDIES ALL-BFM 83 AND 86
    LUDWIG, WD
    TEICHMANN, JV
    SPERLING, C
    KOMISCHKE, B
    RITTER, J
    REITER, A
    ODENWALD, E
    SAUTER, S
    RIEHM, H
    KLINISCHE PADIATRIE, 1990, 202 (04): : 243 - 252
  • [46] Key Treatment Questions in Childhood Acute Lymphoblastic Leukemia: Results in 5 Consecutive Trials Performed by the ALL-BFM Study Group From 1981 to 2000
    Schrappe, M.
    Moericke, A.
    Reiter, A.
    Henze, G.
    Welte, K.
    Gadner, H.
    Ludwig, W. -D.
    Ritter, J.
    Harbott, J.
    Mann, G.
    Klingebiel, T.
    Gruhn, B.
    Niemeyer, C.
    Kremens, B.
    Niggli, F.
    Debatin, K. -M.
    Ratei, R.
    Stanulla, M.
    Beier, R.
    Cario, G.
    Schrauder, A.
    Zimmermann, M.
    KLINISCHE PADIATRIE, 2013, 225 : S62 - S72
  • [47] Acute toxicity of prednisone and dexamethasone in induction therapy of childhood acute lymphoblastic leukemia (ALL): Results of a pilot study from the German ALL-BFM study group.
    Beier, R
    Bode, U
    Ritter, J
    Schwabe, D
    Langer, T
    Scheel-Walter, H
    Mittler, U
    Reiter, A
    Zimmermann, M
    Schrappe, M
    LEUKEMIA, 2001, 15 (03) : 495 - 495
  • [48] Other (Non-CNS/Testicular) Extramedullary Localizations of Childhood Relapsed Acute Lymphoblastic Leukemia and Lymphoblastic Lymphoma-A Report from the ALL-REZ Study Group
    Lissat, Andrej
    van Schewick, Claudia
    Steffen, Ingo G.
    Arakawa, Ayumu
    Bourquin, Jean-Pierre
    Burkhardt, Birgit
    Henze, Guenter
    Mann, Georg
    Peters, Christina
    Sramkova, Lucie
    Eckert, Cornelia
    von Stackelberg, Arend
    Chen-Santel, Christiane
    JOURNAL OF CLINICAL MEDICINE, 2021, 10 (22)
  • [49] Results of the AIEOP-BFM ALL 2000 Study for Childhood Acute Lymphoblastic Leukemia IN AIEOP High Risk Patients
    Conter, Valentino
    Valsecchi, Maria Grazia
    Arico, Maurizio
    Rizzari, Carmelo
    Parasole, Rosanna
    Messina, Chiara
    De Rossi, Giulio
    Barisone, Elena
    Lo Nigro, Luca
    Santoro, Nicola
    Ziino, Ottavio
    Locatelli, Franco
    Pession, Andrea
    Testi, Anna Maria
    Micalizzi, Concetta
    Biondi, Andrea
    Basso, Giuseppe
    Silvestri, Daniela
    Masera, Giuseppe
    BLOOD, 2009, 114 (22) : 135 - 135
  • [50] Prognostic value of minimal residual disease quantificaion prior to allogeneic stem-cell transplantation in relapsed childhood all. Results of the ALL-REZ BFM Study Group
    von Stackelberg, Arend
    Kreyenberg, Hermann
    Eckert, Cornelia
    Borkhardt, Arndt
    Peters, Christina
    Klingebiel, Thomas
    Henze, Guenter
    Bader, Peter
    PEDIATRIC BLOOD & CANCER, 2007, 49 (04) : 436 - 436